12/22
10:04 am
brkr
RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)
Low
Report
RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)
12/18
09:22 am
brkr
AbCellera and Bruker Reach Global Settlement of Patent Litigation [Yahoo! Finance]
Low
Report
AbCellera and Bruker Reach Global Settlement of Patent Litigation [Yahoo! Finance]
12/15
02:24 pm
brkr
Bruker (NASDAQ:BRKR) had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $55.00. They now have an "overweight" rating on the stock.
Low
Report
Bruker (NASDAQ:BRKR) had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $55.00. They now have an "overweight" rating on the stock.
12/15
08:23 am
brkr
Bruker (NASDAQ:BRKR) had its price target raised by analysts at Bank of America Corporation from $43.00 to $60.00. They now have a "buy" rating on the stock.
Low
Report
Bruker (NASDAQ:BRKR) had its price target raised by analysts at Bank of America Corporation from $43.00 to $60.00. They now have a "buy" rating on the stock.
12/15
07:20 am
brkr
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
12/15
06:04 am
brkr
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/12
08:33 am
brkr
Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR) [Yahoo! Finance]
Low
Report
Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR) [Yahoo! Finance]
12/11
07:34 am
brkr
BBH Select Series – Mid Cap Fund Sold Bruker Corporation (BRKR) Due to Policy Uncertainty [Yahoo! Finance]
Low
Report
BBH Select Series – Mid Cap Fund Sold Bruker Corporation (BRKR) Due to Policy Uncertainty [Yahoo! Finance]
12/10
09:08 am
brkr
Bruker (NASDAQ:BRKR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
Low
Report
Bruker (NASDAQ:BRKR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating.
12/10
07:17 am
brkr
Bruker (NASDAQ:BRKR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $40.00 price target on the stock.
Low
Report
Bruker (NASDAQ:BRKR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $40.00 price target on the stock.
12/10
07:17 am
brkr
Bruker (NASDAQ:BRKR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Bruker (NASDAQ:BRKR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
12/10
07:00 am
brkr
Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions
Low
Report
Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions
12/9
05:02 am
brkr
Bruker (NASDAQ:BRKR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating on the stock.
Low
Report
Bruker (NASDAQ:BRKR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating on the stock.
12/8
08:00 am
brkr
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026
Medium
Report
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026
11/24
09:00 am
brkr
Indaba Capital Announces Sale of AST Revolution to Bruker
Low
Report
Indaba Capital Announces Sale of AST Revolution to Bruker
11/21
05:30 am
brkr
Bruker (NASDAQ:BRKR) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.
Medium
Report
Bruker (NASDAQ:BRKR) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.
11/20
10:05 am
brkr
Bruker (NASDAQ:BRKR) was given a new $60.00 price target on by analysts at Redburn Partners.
Medium
Report
Bruker (NASDAQ:BRKR) was given a new $60.00 price target on by analysts at Redburn Partners.
11/20
08:07 am
brkr
Bruker (NASDAQ:BRKR) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $60.00 price target on the stock.
Low
Report
Bruker (NASDAQ:BRKR) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $60.00 price target on the stock.
11/20
07:50 am
brkr
Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum [Yahoo! Finance]
Low
Report
Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum [Yahoo! Finance]
11/5
10:49 am
brkr
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at Wells Fargo & Company from $50.00 to $48.00. They now have an "overweight" rating on the stock.
Low
Report
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at Wells Fargo & Company from $50.00 to $48.00. They now have an "overweight" rating on the stock.
11/4
04:01 pm
brkr
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
Low
Report
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
11/4
02:03 pm
brkr
Bruker (NASDAQ:BRKR) had its price target raised by analysts at TD Cowen from $40.00 to $42.00. They now have a "hold" rating on the stock.
Low
Report
Bruker (NASDAQ:BRKR) had its price target raised by analysts at TD Cowen from $40.00 to $42.00. They now have a "hold" rating on the stock.
11/4
12:09 pm
brkr
Bruker (NASDAQ:BRKR) had its "hold" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Bruker (NASDAQ:BRKR) had its "hold" rating reaffirmed by analysts at Cowen Inc.
11/4
08:43 am
brkr
Bruker (NASDAQ:BRKR) was given a new $43.00 price target on by analysts at UBS Group AG. They now have a "neutral" rating on the stock.
Medium
Report
Bruker (NASDAQ:BRKR) was given a new $43.00 price target on by analysts at UBS Group AG. They now have a "neutral" rating on the stock.
11/4
07:21 am
brkr
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Medium
Report
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.